Mounjaro Step-Up Cheat Sheet: When to Climb

5 min read · doses off DailyMed · last verified November 2026

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

Mounjaro is tirzepatide, injected weekly under the skin, and it is licensed in the United States for type 2 diabetes only. It covers blood sugar control from age 10 up, and in high-risk adults with the disease it also carries a license to lower the odds of a heart attack, a stroke or death from cardiovascular causes. The identical molecule is sold as Zepbound for weight management. The drug and the ladder are the same; the label is not. Prescribing Mounjaro for weight is off-label use of a product whose sibling holds exactly that license.

Because the indication is diabetes, each checkpoint turns on what your blood sugar is doing, not on how much weight has come off.

The ladder

The ladder
Dose Minimum time before moving on What it is
2.5 mg4 weeksA run-up. It is not treating your diabetes; it is letting your stomach get used to the drug.
5 mg4 weeksThe first dose doing real work. A good number of people never need to go past it.
7.5 mg4 weeksOnly worth reaching for if your numbers are still above target.
10 mg4 weeksWhere patients aged 10 to 17 stop. Younger patients stop here.
12.5 mg4 weeksAgain, only if glycemic control is still short.
15 mg—The adult ceiling. Nothing above it is authorized.

Increases go up in 2.5 mg steps and never sooner than four weeks apart.

Climb, hold, or come down

At each four-week checkpoint the decision has more than two options, and “hold” is the one people forget exists.

Climb, hold, or come down
Where you areWhat that argues for
Blood sugar still above target, side effects manageableMove up a step.
Target met, fasting glucose where it should be, feeling fineStay. Climbing further buys you nothing and costs you tolerability.
Nausea, vomiting or diarrhea that is interfering with your dayHold this dose another four weeks. Do not advance into it.
Severe symptoms, dehydration, or bad abdominal painDrop a level or stop, and speak to your prescriber.
Hypoglycemia keeps happening on insulin or a sulfonylureaDo not step up. Bring the other drug down first, then look again.

The usual A1C target is below 7%, but that figure is a default. A younger person at low risk of low blood sugar may be aimed lower, and an older person with other things going on may sensibly be aimed higher. Ask what yours is.

Practical points

  • Same day weekly, any hour, food irrelevant. Abdomen or thigh; the upper arm only if another person does the injecting. Move the site each week and stay off bruised or tender skin.
  • Four weeks is a floor, not a schedule. Eight or twelve weeks at a dose is perfectly reasonable if your numbers are acceptable or your gut still objects.
  • Storage trips people up. Unused pens live in the fridge. A single-dose pen or vial lasts 21 days at room temperature, noticeably shorter than an Ozempic pen's 56. The KwikPen and multi-dose vial go in the trash at the earliest of 30 days from first use, 4 weekly doses, or 30 days in total at room temperature. Do not assume the pens behave alike.
  • Prior authorization for Mounjaro usually turns on a documented A1C and a previous metformin trial. Requests framed around weight alone are commonly refused, because weight is Zepbound's license and not this one's.

A missed dose

  • Within four days (96 hours): get it in when you are able, then return to your normal weekly day.
  • Beyond four days: skip it, and take the next one when it was already due.
  • Moving your injection day is fine so long as 72 hours separate the two doses.
  • Two or more missed in a row is a question for your prescriber, not one to decide alone. Going back a step may be safer than picking up where you left off.

Never take two doses to catch up.

Reasons to stop and call

  • Severe abdominal pain that persists, especially boring through to the back. This can be pancreatitis. Stop the drug and get seen.
  • Right-sided pain under the ribs, fever, yellowing, pale stools. Gallstones showed up more often on tirzepatide than on placebo.
  • Severe hypoglycemia (confusion, collapse, a seizure) where insulin or a sulfonylurea is also in play. The label warns about this combination specifically, and the usual fix is reducing the other drug.
  • A day of not keeping fluids down, dizziness standing up, dark or scanty urine. Kidney injury follows dehydration.
  • A neck lump, a hoarse voice, trouble swallowing. The boxed warning covers thyroid C-cell tumors; medullary thyroid carcinoma in your family or MEN 2 rules the drug out completely.
  • Sight changing, since blood sugar improving fast can briefly worsen diabetic retinopathy.
  • Hives, a swollen face or throat, breathing difficulty. Emergency care.

Outside this page's scope

This page covers dosing for type 2 diabetes only. Ketoacidosis (which can present oddly on incretin therapy), the full workup for suspected pancreatitis, pregnancy, fasting before surgery, the multidose KwikPen instructions, and use after bariatric surgery all need more than a reference card. So does Mounjaro for weight loss, which belongs under Zepbound's license rather than this one.

Where to go next

References

  1. 1.U.S. National Library of Medicine — DailyMed. MOUNJARO (tirzepatide) injection — Structured Product Label. DailyMed (FDA-approved labeling, SetID d2d7da5d-ad07-4228-955f-cf7e355c8cc0). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  2. 2.Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021. PMID: 34170647.

Frequently Asked Questions

Four weeks minimum at your current dose, and increases move in 2.5 mg steps. That is a minimum. Staying eight or twelve weeks at one dose is entirely reasonable if your blood sugar is acceptable or your stomach is still complaining.
Within four days of the missed dose, get it in when you are able, then carry on from your usual day. After four days, leave it out and take the next one when it was already scheduled. Never double up. If two or more consecutive doses have gone by, ask your prescriber before restarting, because dropping back a step may be the safer route.
Whenever your blood sugar is already at target, or when nausea, vomiting or diarrhea is interfering with your day, or when you are getting hypoglycemia alongside insulin or a sulfonylurea. In the last case the other medication needs reducing before anything else changes.
15 mg once weekly for adults. Between the ages of 10 and 17 it drops to 10 mg once weekly, and nothing beyond either limit is authorized.
It is the same molecule from the same manufacturer, on the same ladder, under a different license. Mounjaro carries the diabetes license and Zepbound the weight one, which is why insurers treat them so differently and why a weight-based request under the Mounjaro name is usually refused.

Editorial reference content, not medical advice. Changing a dose, holding one, or stopping altogether is a decision for you and your prescriber together. As for the numbers: we checked every dose figure here against the FDA-approved Structured Product Label on DailyMed in November 2026.

Browse all cheat sheets, top-N research lists, or long-form research deep-dives.